Clinical trial
Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are…
NCT00152503 · UCB Pharma SA, Industry · Completed
Key facts
| NCT number | NCT00152503 |
|---|---|
| Title | Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam |
| Official title | An Open Label, Exploratory, Dose-escalation, Multicenter Study Examining the Safety, Tolerability and Efficacy of Ucb 44212 (Seletracetam) Used at Doses of 10, 20, 40, and 80 mg b.i.d. (Total Daily Doses of 20 - 160 mg) Administration (Oral Capsules) in Adult Subjects (18 - 65 Years) With Refractory… |
| Lead sponsor | UCB Pharma SA, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Epilepsy, Partial |
| Intervention type | Drug |
| Interventions | Seletracetam (UCB44212) |
| Enrollment | 59 |
| Start date | Aug 31, 2005 |
| Primary completion | May 12, 2006 |
| Completion | May 12, 2006 |
| First posted | Sep 9, 2005 |
| Last update posted | Sep 7, 2023 |
| Countries | Canada, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: